ADC Therapeutics (ADCT) Change in Inventory (2023 - 2026)

ADC Therapeutics (ADCT) has reported Change in Inventory for 4 consecutive years, with -$16000.0 the latest figure, recorded in Q1 2026.

• Quarterly Change in Inventory fell 105.23% year-over-year to -$16000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 40.59% YoY) and the FY2025 annual result came in at $2.4 million, down 36.13% from the prior year.
• Change in Inventory declined to -$16000.0 in Q1 2026 per ADCT's latest filing, from $853000.0 in the prior quarter.
• Over the last five years, Change in Inventory for ADCT reached as high as $3.5 million in Q3 2023 and fell as low as -$518000.0 in Q2 2024.
• A 4-year average of $908076.9 and a median of $568000.0 in 2024 frame the typical range for Change in Inventory.
• The largest YoY upside for Change in Inventory was 1775.45% in 2024 against a maximum downside of 125.24% in 2024.
• Year by year, Change in Inventory stood at -$167000.0 in 2023, then soared by 1775.45% to $2.8 million in 2024, then slumped by 69.51% to $853000.0 in 2025, then tumbled by 101.88% to -$16000.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$16000.0, $853000.0, and $516000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.